Metraipolis › archive › dc_d8cb19680716

Endostar combined with docetaxel or cisplatin in the management of malignant ascites through hyperthermic intraperitoneal chemotherapy: A retrospective cohort… — Europe PMC PMID:41613583

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41613583
DOI
10.3892/ol.2026.15463
License (as archived)
solo-consultazione
Archived
2026-11-06T19:42:20.487Z
SHA-256 of the archived text
6bc8fc8dc7b41f06c35a5b818b8c989924d933d763686829d89a5434cb529a7d
Stable URL of this page
https://metraipolis.com/documento/dc_d8cb19680716

How to cite

Endostar combined with docetaxel or cisplatin in the management of malignant ascites through hyperthermic intraperitoneal chemotherapy: A retrospective cohort… — Europe PMC PMID:41613583 — Europe PMC (en), https://europepmc.org/article/MED/41613583 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d8cb19680716 (Metraipolis archive dc_d8cb19680716, sha256 6bc8fc8dc7b41f06c35a5b818b8c989924d933d763686829d89a5434cb529a7d)
BibTeX
@misc{dcd8cb19680716,
  title = {Endostar combined with docetaxel or cisplatin in the management of malignant ascites through hyperthermic intraperitoneal chemotherapy: A retrospective cohort… — Europe PMC PMID:41613583},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41613583},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d8cb19680716; sha256 6bc8fc8dc7b41f06c35a5b818b8c989924d933d763686829d89a5434cb529a7d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41613583. Agents can read the archived copy with the MCP tool read_document.